Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications

被引：23
|
作者：
Magee, CJ [1 ]
Greenhalf, W [1 ]
Howes, N [1 ]
Ghaneh, P [1 ]
Neoptolemos, JP [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Dept Surg, Liverpool L69 3GA, Merseyside, England
来源：
SURGICAL ONCOLOGY-OXFORD | 2001年 / 10卷 / 1-2期
关键词：
pancreatic cancer; hereditary pancreatitis; pathogenesis; screening; treatment;
D O I：
10.1016/S0960-7404(01)00016-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Pancreatic ductal adenocarcinoma (PDAC) is a significant cause of cancer death worldwide. PDAC is also one of the best-studied cancers with regard to molecular pathogenesis. The chief risk factors associated with PDAC are smoking and pancreatitis, in addition genetic predisposition seems to play a major role. This genetic predisposition may in some cases be indirect, for example via the elevated risk of pancreatitis seen in patients with hereditary pancreatitis (HP). The elucidation of the molecular causes of PDAC has enabled the provision of secondary screening for PDAC in conditions such as HP. This review is concerned with the molecular pathogenesis of PDAC and the application of this basic scientific understanding into state-of-the-art clinical practice. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1 / 23
页数：23
相关论文
共 50 条
  • [21] The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
    Samuel, Nardin
    Hudson, Thomas J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (02) : 77 - 87
  • [22] Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma
    Lee, Jaewon James
    Yeh, Jen Jen
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (05) : 939 - 950
  • [23] The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
    Nardin Samuel
    Thomas J. Hudson
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 77 - 87
  • [24] Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma
    Yousef, Mahmoud
    Hurd, Mark W.
    Yousef, Abdelrahman
    Ludmir, Ethan B.
    Pillai, Ashwathy B.
    Peterson, Jennifer
    Koay, Eugene J.
    Albarouki, Sali
    Tzeng, Ching-Wei
    Snyder, Rebecca
    Katz, Matthew H. G.
    Wang, Huamin
    Overman, Michael J.
    Maitra, Anirban
    Pant, Shubham
    Smaglo, Brandon G.
    Wolff, Robert A.
    Yao, James
    Shen, John P.
    Zhao, Dan
    ONCOLOGIST, 2024, 30 (01):
  • [25] Clinical Potential of MicroRNAs in Pancreatic Ductal Adenocarcinoma
    Steele, Colin W.
    Oien, Karin A.
    McKay, Colin J.
    Jamieson, Nigel B.
    PANCREAS, 2011, 40 (08) : 1165 - 1171
  • [26] Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
    Li, Ruiyu
    He, Yangzhige
    Zhang, Hui
    Wang, Jing
    Liu, Xiaoding
    Liu, Hangqi
    Wu, Huanwen
    Liang, Zhiyong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
    Caitlyn Smith
    Wei Zheng
    Jixin Dong
    Yaohong Wang
    Jinping Lai
    Xiuli Liu
    Feng Yin
    World Journal of Gastroenterology, 2022, 28 (27) : 3297 - 3313
  • [28] Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
    Smith, Caitlyn
    Zheng, Wei
    Dong, Jixin
    Wang, Yaohong
    Lai, Jinping
    Liu, Xiuli
    Yin, Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (27) : 3297 - 3313
  • [29] Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma
    Cloyd, Jordan M.
    Katz, Matthew H. G.
    Wang, Huamin
    Cuddy, Amanda
    You, Y. Nancy
    JAMA SURGERY, 2017, 152 (11) : 1086 - 1088
  • [30] Biomarker Discovery and Molecular Imaging of Pancreatic Ductal Adenocarcinoma
    Kelly, K.
    MEDICAL PHYSICS, 2009, 36 (06)
12345